Serial 97230017
Live / Registered — Registered (as of 07 Jan 2025)
What this means for you
Registered since 07 Jan 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97230017
- Registration number
- 7637260
- Mark type
- Design / logo
- Filed
- 20 Jan 2022
- Published for opposition
- 17 Sept 2024
- Registered
- 07 Jan 2025
- Attorney of record
- Timothy T. Wang
Goods and services
- Class 042 — Scientific and technological services: Biomedical research services; Biotechnology research; Chemical research; Chemical research and analysis; Chemistry consultation; Development and test of chemical production methods; Development of pharmaceutical preparations and medicines; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical research and development; Professional consulting services and advice about agricultural chemistry; Providing medical and scientific research information in the field of clinical trials; Research and development in the field of antibody-drug conjugates; Research and development in the field of antibody conjugates; Research and development in the field of drug conjugates; Research and development services in the field of antibodies; Research in the field of chemistry; Scientific research for medical purposes in the area of cancerous diseases; Scientific research in the nature of conducting clinical trials for others; Technology research in the field of pharmaceutical preparations and medical instruments; Testing of cosmetics; Testing of pharmaceuticals
Owner
- MediLink Therapeutics(Suzhou)Co.,Ltd., Suzhou, Jiangsu, CN
- MediLink Therapeutics(Suzhou)Co.,Ltd., Suzhou, Jiangsu, CN
- MediLink Therapeutics(Suzhou)Co.,Ltd., Suzhou, Jiangsu, CN
Prosecution history
- 07 Jan 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Jan 2025 — REGISTERED-PRINCIPAL REGISTER
- 17 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Sept 2024 — PUBLISHED FOR OPPOSITION
- 28 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Aug 2024 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 14 Aug 2024 — PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
- 13 Aug 2024 — ASSIGNED TO PETITION STAFF
- 11 Jul 2024 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 11 Jul 2024 — TEAS PETITION TO AMEND BASIS RECEIVED
- 16 Apr 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 04 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Feb 2024 — PUBLISHED FOR OPPOSITION
- 31 Jan 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Jan 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED